Jacobs Levy Equity Management’s Dentsply Sirona XRAY Stock Holding History
Bought
Maintained
Sold
Other funds holding XRAY
VPM
SCA
VCM
CB
AI
Jacobs Levy Equity Management's XRAY Position: Q1 2026 in Review
Jacobs Levy Equity Management reduced its Dentsply Sirona (XRAY) stake by 77% in Q1 2026, selling an estimated $29.9M and leaving 722,268 shares worth $8.38M. The position accounts for 0.04% of the portfolio, ranked #333.
Jacobs Levy Equity Management first reported a position in XRAY in Q2 2019 and has held it in 14 quarters since. The position peaked at $58.5M in Q3 2025. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.
- Jacobs Levy Equity Management held 722,268 shares of Dentsply Sirona worth $8.38M as of Q1 2026.
- Jacobs Levy Equity Management sold 2,399,725 Dentsply Sirona shares in Q1 2026, an estimated $29.9M.
- Dentsply Sirona made up 0.04% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #333 holding.
- Jacobs Levy Equity Management first reported a position in Dentsply Sirona in Q2 2019 and has held it in 14 quarters since.
- Jacobs Levy Equity Management's Dentsply Sirona position peaked at $58.5M in Q3 2025.
- 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.